PTEN Clinical Trials

2 recruiting

PTEN Trials at a Glance

7 actively recruiting trials for pten are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 1 trial, with the heaviest enrollment activity in New York, Boston, and Cincinnati. Lead sponsors running pten studies include Boston Children's Hospital, Deborah Doroshow, and Atlas University.

Browse pten trials by phase

Treatments under study

About PTEN Clinical Trials

Looking for clinical trials for PTEN? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new PTEN trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about PTEN clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

Natural History With Focus on Oncological Risk Evaluation in Pediatric Patients With PTEN Pathogenic Variants

PTEN Hamartoma Syndrome
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta50 enrolled1 locationNCT06805734
Recruiting

PTEN and Organ-Specific microRNAs in Metastatic Breast Cancer

Breast CancerMetastatic Breast CancermiRNAs+1 more
Atlas University160 enrolled1 locationNCT07297134
Recruiting

PTEN Hamartoma Tumor Syndrome Pediatric Patient Registry

PTEN Hamartoma Tumor SyndromeMacrocephaly Autism Syndrome
Yale University100 enrolled1 locationNCT06462430
Recruiting

Cancer Risk Assessment in Patients With a Constitutional Alteration of the PTEN Gene

PTEN Gene Mutation
Institut Bergonié430 enrolled1 locationNCT05630105
Recruiting
Not Applicable

An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results

BRCA1 MutationBRCA2 MutationPOLD1 Gene Mutation+19 more
Memorial Sloan Kettering Cancer Center1,000 enrolled8 locationsNCT05420064
Recruiting
Phase 1

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
Deborah Doroshow24 enrolled1 locationNCT04997993
Recruiting

Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations

PTENAutismPTEN Hamartoma Tumor Syndrome+2 more
Boston Children's Hospital170 enrolled5 locationsNCT02461446